For the quarter ending 2025-09-30, ENVB has $4,362,061 in assets.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 3,757,594 | 2,849,816 | ||
| Prepaid expenses and other current assets | 407,946 | 457,556 | ||
| Total current assets | 4,165,540 | 3,307,372 | ||
| Property and equipment, net | 196,521 | 241,082 | ||
| Intangible assets, net | - | 0 | ||
| Total other assets | 196,521 | 241,082 | ||
| Total assets | 4,362,061 | 3,548,454 | ||
| Total mezzanine equity | 0 | 0 | ||
| Due to related parties-Related Party | - | 99,875 | ||
| Due to related parties | 0 | - | ||
| Accounts payable | 683,707 | 1,040,967 | ||
| Accrued expenses and other current liabilities | 222,178 | 222,843 | ||
| Total current liabilities | 905,885 | 1,363,685 | ||
| Common stock, 0.01 par value, 100,000,000 shares authorized, 518,296 and 56,501 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 5,183 | 30,260 | ||
| Additional paid-in capital | 116,684,259 | 113,506,692 | ||
| Accumulated other comprehensive loss | -580,945 | -573,531 | ||
| Accumulated deficit | -112,652,321 | -110,778,652 | ||
| Total shareholders equity | 3,456,176 | 2,184,769 | ||
| Total liabilities, mezzanine equity, and shareholders equity | 4,362,061 | 3,548,454 | ||
Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (ENVB)